Skip to Content

Parathyroid hormone Pregnancy and Breastfeeding Warnings

Parathyroid hormone is also known as: Natpara

Medically reviewed on Mar 5, 2018

Parathyroid hormone Pregnancy Warnings

This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

US FDA pregnancy category: C

Increased incidence of morbidity associated with dehydration, broken palate, palate injuries related to incisor misalignment, and mortality were found in animal studies. There are no adequate and well-controlled studies in pregnant women.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Parathyroid hormone Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Yes

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Natpara (parathyroid hormone)." NPS Pharmaceuticals, Bedminster, NJ.

References for breastfeeding information

  1. "Product Information. Natpara (parathyroid hormone)." NPS Pharmaceuticals, Bedminster, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide